A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
Open Access
- 1 April 2010
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 17 (4), 400-411
- https://doi.org/10.1016/j.ccr.2009.12.050
Abstract
No abstract availableKeywords
Funding Information
- Canadian Cancer Society
- Leukemia and Lymphoma Society
- National Cancer Institute (R01 CA104348)
- National Institutes of Health (HL082670, CA107331, CA120215)
- University of Maryland Foundation Inc.
- Chemotherapy Foundation
- Samuel Waxman Cancer Research Foundation
This publication has 52 references indexed in Scilit:
- BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cellsBlood Cells, Molecules, and Diseases, 2008
- Structure of a BCOR Corepressor Peptide in Complex with the BCL6 BTB Domain DimerMolecular Cell, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomasProceedings of the National Academy of Sciences, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- The Protein Data BankNucleic Acids Research, 2000
- All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of ProteinsThe Journal of Physical Chemistry B, 1998
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D-Biological Crystallography, 1997
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983